Lille, France

Anne Gayot

This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Gayot. Retrieved from https://idiyas.com/inventor/anne-gayot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anne Gayot: Innovator in Periodontal Treatment

Introduction

Anne Gayot is a notable inventor based in Lille, France. She has made significant contributions to the field of periodontal treatment through her innovative work. Her research focuses on developing effective pharmaceutical compositions for treating periodontal complaints.

Latest Patents

Anne Gayot holds a patent for a method for the treatment of periodontal pockets with a composition. This invention relates to a composition that combines collagen with an antiseptic and/or anti-inflammatory active principle. The pharmaceutical composition comprises collagen as the vehicle and at least one antiseptic and/or inflammatory substance as the active principle. This innovative approach aims to provide a topical treatment for periodontal complaints.

Career Highlights

Anne Gayot is associated with Pierre Fabre Medicament, where she applies her expertise in developing pharmaceutical solutions. Her work has been instrumental in advancing treatments for periodontal issues, showcasing her commitment to improving oral health.

Collaborations

Throughout her career, Anne has collaborated with notable colleagues, including Genevieve Thomas-Leurquin and Pierre Poitou. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Anne Gayot's contributions to periodontal treatment through her innovative patent highlight her role as a leading inventor in the field. Her work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…